HEAD START 4: NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS

Brief description of study

If your child has been diagnosed with medulloblastoma or other central nervous system embryonal tumors, your child may qualify to participate in a study.  The main goal of this randomized trial is to compare single consolidation versus tandem (3 cycles) consolidation regimen provides the same outcome.  Also this study will determine if through the reduction of chemotherapy cycles, results in lower long term toxicities, in particular ototoxicity.


Clinical Study Identifier: s17-00351
ClinicalTrials.gov Identifier: NCT02875314


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.